Related references
Note: Only part of the references are listed.Lineage Identity and Location within the Dermis Determine the Function of Papillary and Reticular Fibroblasts in Human Skin
Ana Korosec et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2019)
IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma
Giulia Biffi et al.
CANCER DISCOVERY (2019)
HIF2A-LOX Pathway Promotes Fibrotic Tissue Remodeling in Thyroid-Associated Orbitopathy
Fumihito Hikage et al.
ENDOCRINOLOGY (2019)
Mechanoreciprocity in cell migration
Sjoerd van Helvert et al.
NATURE CELL BIOLOGY (2018)
A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia
David Martinez-Cuadron et al.
ANNALS OF HEMATOLOGY (2018)
Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer
Ana Costa et al.
CANCER CELL (2018)
A peek into cancer-associated fibroblasts: origins, functions and translational impact
Valerie S. LeBleu et al.
DISEASE MODELS & MECHANISMS (2018)
Enduring epigenetic landmarks define the cancer microenvironment
Ruth Pidsley et al.
GENOME RESEARCH (2018)
Periostin promotes liver fibrogenesis by activating lysyl oxidase in hepatic stellate cells
Pradeep Kumar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
SFRP2/DPP4 and FMO1/LSP1 Define Major Fibroblast Populations in Human Skin
Tracy Tabib et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
Spatial and Single-Cell Transcriptional Profiling Identifies Functionally Distinct Human Dermal Fibroblast Subpopulations
Christina Philippeos et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
Phenotype molding of stromal cells in the lung tumor microenvironment
Diether Lambrechts et al.
NATURE MEDICINE (2018)
Targeting the tumour stroma to improve cancer therapy
Kenneth C. Valkenburg et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
LOXL2, a copper-dependent monoamine oxidase, activates lung fibroblasts through the TGF-β/Smad pathway
Xiaohong Wen et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2018)
IGFBP-5 Promotes Fibrosis via Increasing Its Own Expression and That of Other Pro-fibrotic Mediators
Xinh-Xinh Nguyen et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Blocking Autophagy in Cancer-Associated Fibroblasts Supports Chemotherapy of Pancreatic Cancer Cells
Xianbin Zhang et al.
FRONTIERS IN ONCOLOGY (2018)
The evolving relationship of wound healing and tumor stroma
Deshka S. Foster et al.
JCI INSIGHT (2018)
TGFβR1 Blockade with Galunisertib (LY2157299) Enhances Anti-Neuroblastoma Activity of the Anti-GD2 Antibody Dinutuximab (ch14.18) with Natural Killer Cells
Hung C. Tran et al.
CLINICAL CANCER RESEARCH (2017)
Periostin regulates fibrocyte function to promote myofibroblast differentiation and lung fibrosis
S. L. Ashley et al.
MUCOSAL IMMUNOLOGY (2017)
A Phase 1/1b tolerability study of rilotumumab alone or in combination with cisplatin and capecitabine in Japanese patients with gastric cancer
Toshihiko Doi et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2017)
Cancer-associated fibroblasts promote directional cancer cell migration by aligning fibronectin
Begum Erdogan et al.
JOURNAL OF CELL BIOLOGY (2017)
Cancer-associated fibroblasts lead tumor invasion through integrin-β3-dependent fibronectin assembly
Youmna Attieh et al.
JOURNAL OF CELL BIOLOGY (2017)
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
Daniel Ohlund et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Rilotumumab plus epirubicin, cisplatin, and capecitabine as first-line therapy in advanced MET-positive gastric or gastro-oesophageal junction cancer (RILOMET-1): a randomised, double-blind, placebo-controlled, phase 3 trial
Daniel V. T. Catenacci et al.
LANCET ONCOLOGY (2017)
Revisiting Seed and Soil: Examining the Primary Tumor and Cancer Cell Foraging in Metastasis
Amber E. de Groot et al.
MOLECULAR CANCER RESEARCH (2017)
A mechanically active heterotypic E-cadherin/N-cadherin adhesion enables fibroblasts to drive cancer cell invasion
Anna Labernadie et al.
NATURE CELL BIOLOGY (2017)
Reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors
Huipeng Li et al.
NATURE GENETICS (2017)
A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Simtuzumab in Combination with FOLFIRI for the Second-Line Treatment of Metastatic KRAS Mutant Colorectal Adenocarcinoma
J. Randolph Hecht et al.
ONCOLOGIST (2017)
A Phase II Randomized, Double-Blind, Placebo-Controlled Study of Simtuzumab or Placebo in Combination with Gemcitabine for the First-Line Treatment of Pancreatic Adenocarcinoma
Al B. Benson et al.
ONCOLOGIST (2017)
Targeted apoptosis of myofibroblasts with the BH3 mimetic ABT-263 reverses established fibrosis
David Lagares et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Tenascin-C induces migration and invasion through JNK/c-Jun signalling in pancreatic cancer
Jun Cai et al.
ONCOTARGET (2017)
Pre-clinical evaluation of small molecule LOXL2 inhibitors in breast cancer
Joan Chang et al.
ONCOTARGET (2017)
The fibronectin synergy site re-enforces cell adhesion and mediates a crosstalk between integrin classes
Maria Benito-Jardon et al.
ELIFE (2017)
Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer
Sidharth V. Puram et al.
CELL (2017)
A Randomized, Placebo-Controlled, Phase 1b/2 Study of Rilotumumab or Ganitumab in Combination With Platinum-Based Chemotherapy as First-Line Treatment for Extensive-Stage Small-Cell Lung Cancer
Bonnie Glisson et al.
CLINICAL LUNG CANCER (2017)
Microenvironmental regulation of tumour angiogenesis
Michele de Palma et al.
NATURE REVIEWS CANCER (2017)
Phase 1/2 Study of Rilotumumab (AMG 102), a Hepatocyte Growth Factor Inhibitor, and Erlotinib in Patients With Advanced Non-Small Cell Lung Cancer
Ahmad A. Tarhini et al.
CANCER (2017)
Tenascin-C is a potential cancer-associated fibroblasts marker and predicts poor prognosis in prostate cancer
Wei-Dong Ni et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Lysyl Oxidase and the Tumor Microenvironment
Tong-Hong Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Inhibition of Ovarian Tumor Growth by Targeting the HU177 Cryptic Collagen Epitope
Jennifer M. Caron et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
Lysyl oxidase expression in cardiac fibroblasts is regulated by α2β1 integrin interactions with the cellular microenvironment
Albert E. Gao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Transforming growth factor β as regulator of cancer stemness and metastasis
Claudia Bellomo et al.
BRITISH JOURNAL OF CANCER (2016)
FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3-CCL2 Signaling
Xuguang Yang et al.
CANCER RESEARCH (2016)
Serum Level of Matrix Metalloproteinase-9 in Patients with Head and Neck Squamous Cell Carcinoma
Adina E. Stanciu et al.
CLINICAL LABORATORY (2016)
Expressions of Matrix Metalloproteinases 2, 7, and 9 in Carcinogenesis of Pancreatic Ductal Adenocarcinoma
Katarzyna Jakubowska et al.
DISEASE MARKERS (2016)
Cancer-associated fibroblasts promote the progression of endometrial cancer via the SDF-1/CXCR4 axis
Fei Teng et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Matrix metalloproteinase-9 and-2 and tissue inhibitor of matrix metalloproteinase-2 in invasive pituitary adenomas A systematic review and meta-analysis of case-control trials
Hong-Yan Liu et al.
MEDICINE (2016)
Expression of metalloproteinases (MMP-2 and MMP-9) in basal-cell carcinoma
Anna Gozdzialska et al.
MOLECULAR BIOLOGY REPORTS (2016)
A tenascin C targeted nanoliposome with navitoclax for specifically eradicating of cancer-associated fibroblasts
Binlong Chen et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2016)
A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma
Alba A. Brandes et al.
NEURO-ONCOLOGY (2016)
Myofibroblasts are distinguished from activated skin fibroblasts by the expression of AOC3 and other associated markers
Lin-ting Hsia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Worse prognosis in breast cancer patients can be predicted by immunohistochemical analysis of positive MMP-2 and negative estrogen and progesterone receptors
Edneia A. S. Ramos et al.
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA (2016)
Genetic lineage tracing defines myofibroblast origin and function in the injured heart
Onur Kanisicak et al.
NATURE COMMUNICATIONS (2016)
Prognostic impact of serum and tissue MMP-9 in non-small cell lung cancer: a systematic review and meta-analysis
Liang Gong et al.
ONCOTARGET (2016)
Emerging role of LOXL2 in the promotion of pancreas cancer metastasis
Joon Seong Park et al.
ONCOTARGET (2016)
MMP2 and MMP9 serum levels are associated with favorable outcome in patients with inflammatory breast cancer treated with bevacizumab-based neoadjuvant chemotherapy in the BEVERLY-2 study
Emeline Tabouret et al.
ONCOTARGET (2016)
Prognostic value of MMP9 activity level in resected stage I B lung adenocarcinoma
Yongfeng Yu et al.
CANCER MEDICINE (2016)
Comparison of MMP2 and MMP9 expression levels between primary and metastatic regions of oral squamous cell carcinoma
Kensuke Nishio et al.
JOURNAL OF ORAL SCIENCE (2016)
Comparative Analysis of Matrix Metalloproteinase Family Members Reveals That MMP9 Predicts Survival and Response to Temozolomide in Patients with Primary Glioblastoma
Qingbin Li et al.
PLOS ONE (2016)
Inhibition of Lysyl Oxidase and Lysyl Oxidase-Like Enzymes Has Tumour-Promoting and Tumour-Suppressing Roles in Experimental Prostate Cancer
Maria Nilsson et al.
SCIENTIFIC REPORTS (2016)
Remodeling of extracellular matrix by normal and tumor-associated fibroblasts promotes cervical cancer progression
Alexandra Fullar et al.
BMC CANCER (2015)
Intralesional administration of L19-IL2/L19-TNF in stage III or stage IVM1a melanoma patients: results of a phase II study
Riccardo Danielli et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
LOXL2 Is Highly Expressed in Cancer-Associated Fibroblasts and Associates to Poor Colon Cancer Survival
Sofia Torres et al.
CLINICAL CANCER RESEARCH (2015)
Tenascin-C: Its functions as an integrin ligand
Richard P. Tucker et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2015)
Podoplanin-expressing cancer-associated fibroblasts lead and enhance the local invasion of cancer cells in lung adenocarcinoma
Shinya Neri et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
The Expression of Tumor-Derived and Stromal-Derived Matrix Metalloproteinase 2 Predicted Prognosis of Ovarian Cancer
Ziyi Fu et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2015)
Prognostic effect of matrix metalloproteinase-9 in patients with resected Non small cell lung cancer
Chang Young Lee et al.
JOURNAL OF CARDIOTHORACIC SURGERY (2015)
Has the search for a marker of activated fibroblasts finally come to an end?
W. Matthijs Blankesteijn
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2015)
Stromal matrix metalloproteinase 2 regulates collagen expression and promotes the outgrowth of experimental metastases
Andreia L. Bates et al.
JOURNAL OF PATHOLOGY (2015)
Cancer-associated fibroblast-derived CXCL12 causes tumor progression in adenocarcinoma of the esophagogastric junction
Hidetaka Sugihara et al.
MEDICAL ONCOLOGY (2015)
Origin and Function of Myofibroblasts in the Liver
Rebecca G. Wells et al.
SEMINARS IN LIVER DISEASE (2015)
The tumor-targeting immunocytokine F16-IL2 in combination with doxorubicin: dose escalation in patients with advanced solid tumors and expansion into patients with metastatic breast cancer
Chiara Catania et al.
CELL ADHESION & MIGRATION (2015)
Inhibition of Lysyl Oxidases Improves Drug Diffusion and Increases Efficacy of Cytotoxic Treatment in 3D Tumor Models
Friedrich Schuetze et al.
SCIENTIFIC REPORTS (2015)
Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth
Kazuyoshi Shiga et al.
CANCERS (2015)
The Impact of Matrix Metalloproteinase 2 on Prognosis and Clinicopathology of Breast Cancer Patients: A Systematic Meta-Analysis
Yiping Chen et al.
PLOS ONE (2015)
Selective Allosteric Inhibition of MMP9 Is Efficacious in Preclinical Models of Ulcerative Colitis and Colorectal Cancer
Derek C. Marshall et al.
PLOS ONE (2015)
Cellular Sources of Tenascin-C in Canine Mammary Carcinomas
H. Yoshimura et al.
VETERINARY PATHOLOGY (2015)
Elevated expression levels of androgen receptors and matrix metalloproteinase-2 and-9 in 30 cases of hepatocellular carcinoma compared with adjacent tissues as predictors of cancer invasion and staging
Yan Zhang et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2015)
Expression levels of matrix metalloproteinase-9 in human gastric carcinoma
Su-Zuan Chen et al.
ONCOLOGY LETTERS (2015)
Association of Matrix Metalloproteinase (MMP)-2 and-9 Expression with Extra- gastrointestinal Stromal Tumor Metastasis
Chao Wang et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
The MMP-2-735 C Allele is a Risk Factor for Susceptibility to Breast Cancer
Kheirollah Yari et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
MMP-9 expression varies according to molecular subtypes of breast cancer
Einas M. Yousef et al.
BMC CANCER (2014)
Cancer-associated fibroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF-β signalling
Y. Yu et al.
BRITISH JOURNAL OF CANCER (2014)
Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival
Berna C. Oezdemir et al.
CANCER CELL (2014)
Lysyl oxidase-like 2 (LOXL2) from stromal fibroblasts stimulates the progression of gastric cancer
Hiroaki Kasashima et al.
CANCER LETTERS (2014)
Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis
Thomas Moore-Morris et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Human mesenchymal stem cells express a myofibroblastic phenotype in vitro: comparison to human cardiac myofibroblasts
Melanie A. Ngo et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2014)
Is there new hope for therapeutic matrix metalloproteinase inhibition?
Roosmarijn E. Vandenbroucke et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Association of matrix metalloproteinase 2 plasma level with response and survival in patients treated with bevacizumab for recurrent high-grade glioma
Emeline Tabouret et al.
NEURO-ONCOLOGY (2014)
Fibronectin expression in glioblastomas promotes cell cohesion, collective invasion of basement membrane in vitro and orthotopic tumor growth in mice
E. Serres et al.
ONCOGENE (2014)
Phase I Study of GC1008 (Fresolimumab): A Human Anti-Transforming Growth Factor-Beta (TGFβ) Monoclonal Antibody in Patients with Advanced Malignant Melanoma or Renal Cell Carcinoma
John C. Morris et al.
PLOS ONE (2014)
Expression and Clinical Significance of Matrix Metalloproteinase-9 in Lymphatic Invasiveness and Metastasis of Breast Cancer
Qiu-Wan Wu et al.
PLOS ONE (2014)
Serum levels and tissue expression of matrix metalloproteinase 2 (MMP-2) and tissue inhibitor of metalloproteinases 2 (TIMP-2) in colorectal cancer patients
Magdalena Groblewska et al.
TUMOR BIOLOGY (2014)
The expression of MMP-2 and Ki-67 in head and neck melanoma, and their correlation with clinic-pathologic indices
Kambiz Kamyab-Hesari et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2014)
Fibroblasts and myofibroblasts in wound healing
Ian A. Darby et al.
CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY (2014)
Hepatocyte growth factor activates tumor stromal fibroblasts to promote tumorigenesis in gastric cancer
Xiongyan Wu et al.
CANCER LETTERS (2013)
TGF-β Modulates Ovarian Cancer Invasion by Upregulating CAF-Derived Versican in the Tumor Microenvironment
Tsz-Lun Yeung et al.
CANCER RESEARCH (2013)
Stromally Derived Lysyl Oxidase Promotes Metastasis of Transforming Growth Factor-β-Deficient Mouse Mammary Carcinomas
Michael W. Pickup et al.
CANCER RESEARCH (2013)
Microenvironment and tumor progression of melanoma: New therapeutic prospectives
Gerardo Botti et al.
JOURNAL OF IMMUNOTOXICOLOGY (2013)
Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts
Fernando Calvo et al.
NATURE CELL BIOLOGY (2013)
The history of matrix metalloproteinases: milestones, myths, and misperceptions
Rugmani Padmanabhan Iyer et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2012)
Prognostic Impact of Cancer-Associated Stromal Cells in Patients With Stage I Lung Adenocarcinoma
Masami Ito et al.
CHEST (2012)
What's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis
Keiko Iwaisako et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
Different Gene Expression Patterns in Human Papillary and Reticular Fibroblasts
David G. Janson et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
Ravid Straussman et al.
NATURE (2012)
Transmembrane Collagen Receptors
Birgit Leitinger
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 27 (2011)
Bone Marrow-Derived Myofibroblasts Contribute to the Mesenchymal Stem Cell Niche and Promote Tumor Growth
Michael Quante et al.
CANCER CELL (2011)
Tenascin-C triggers fibrin accumulation by downregulation of tissue plasminogen activator
Florence Brellier et al.
FEBS LETTERS (2011)
Phase II AIDS Malignancy Consortium Trial of Topical Halofuginone in AIDS-Related Kaposi Sarcoma
Henry B. Koon et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2011)
Fibroblasts and Myofibroblasts: What Are We Talking About?
Jennifer Baum et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2011)
Breast Cancer Cells Induce Cancer-Associated Fibroblasts to Secrete Hepatocyte Growth Factor to Enhance Breast Tumorigenesis
Shiaw-Wei Tyan et al.
PLOS ONE (2011)
An overview of the c-MET signaling pathway
Shawna Leslie Organ et al.
Therapeutic Advances in Medical Oncology (2011)
Cancer associated fibroblasts (CAFs) in tumor microenvironment
Fei Xing et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2010)
The Fibroblast Integrin α11β1 Is Induced in a Mechanosensitive Manner Involving Activin A and Regulates Myofibroblast Differentiation
Sergio Carracedo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Final results from a phase I study of TRC093 (humanized anti-cleaved collagen antibody) in patients with solid cancer.
F. Robert et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment
Vivian Barry-Hamilton et al.
NATURE MEDICINE (2010)
The final steps of integrin activation: the end game
Sanford J. Shattil et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Heterogeneity of gene expression in stromal fibroblasts of human breast carcinomas and normal breast
M. Bauer et al.
ONCOGENE (2010)
Inhibition of Pancreatic Stellate Cell Activation by Halofuginone Prevents Pancreatic Xenograft Tumor Development
Itai Spector et al.
PANCREAS (2010)
The polarization of immune cells in the tumour environment by TGFβ
Richard A. Flavell et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Effective immunoconjugate therapy in cancer models targeting a serine protease of tumor fibroblasts
Elinborg Ostermann et al.
CLINICAL CANCER RESEARCH (2008)
Formation and activation of fibroblast spheroids depend on fibronectin-integrin interaction
Pertteli Salmenpera et al.
EXPERIMENTAL CELL RESEARCH (2008)
Cancer as an overhealing wound:: an old hypothesis revisited
Matthias Schaefer et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts
Elisabeth M. Zeisberg et al.
CANCER RESEARCH (2007)
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
Elisabeth M. Zeisberg et al.
NATURE MEDICINE (2007)
Integrin all regulates IGF2 expression in fibroblasts to enhance tumorigenicity of human non-small-cell lung cancer cells
Chang-Qi Zhu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The myofibroblast - One function, multiple origins
Boris Hinz et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Disruption of endothelial cell interactions with the novel HU177 cryptic collagen epitope inhibits angiogenesis
Alexandra Cretu et al.
CLINICAL CANCER RESEARCH (2007)
Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic
Mingfang Ao et al.
CANCER RESEARCH (2007)
Fibroblasts and myofibroblasts: Their source, function and role in disease
Robin J. McAnulty
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
Phase I and pharmacokinetic study of halofuginone, an oral quinazolinone derivative in patients with advanced solid tumours
M. J. A. de Jonge et al.
EUROPEAN JOURNAL OF CANCER (2006)
Halofuginone suppresses the lung metastasis of chemically induced hepatocellular carcinoma in rats through MMP inhibition
Daniele Taras et al.
NEOPLASIA (2006)
Tensional homeostasis and the malignant phenotype
MJ Paszek et al.
CANCER CELL (2005)
Integrins control motile strategy through a Rho-cofilin pathway
EHJ Danen et al.
JOURNAL OF CELL BIOLOGY (2005)
Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion
A Orimo et al.
CELL (2005)
Fibrocytes contribute to the myofibroblast population in wounded skin and originate from the bone marrow
L Mori et al.
EXPERIMENTAL CELL RESEARCH (2005)
Combined total genome loss of heterozygosity scan of breast cancer stroma and epithelium reveals multiplicity of stromal targets
K Fukino et al.
CANCER RESEARCH (2004)
Stromal antigen targeting by a humanised monoclonal antibody:: An early phase II trial of sibrotuzamab in patients with metastatic colorectal cancer
RD Hofheinz et al.
ONKOLOGIE (2003)
Mechanical force regulation of myofibroblast differentiation in cardiac fibroblasts
J Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2003)
Growth inhibition of prostate cancer xenografts by halofuginone
Z Gavish et al.
PROSTATE (2002)
Share Paper
